These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2894215)

  • 1. Ketanserin in essential hypertension: use as monotherapy and in combination with a diuretic or beta-adrenoceptor antagonist.
    Cameron HA; Waller PC; Ramsay LE
    Br J Clin Pharmacol; 1987 Dec; 24(6):705-11. PubMed ID: 2894215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ketanserin and slow-release nifedipine added to the treatment of hypertensive patients uncontrolled by a thiazide diuretic plus beta-adrenoceptor blocker.
    Waller PC; Solomon SA; Ramsay LE
    Br J Clin Pharmacol; 1987 Nov; 24(5):591-7. PubMed ID: 2893636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive efficacy of ketanserin alone or in combination with a beta-blocker or a diuretic: the Swiss Ketanserin Study.
    Beretta-Piccoli C; Amstein R; Bertel O; Brunner HR; Bühler FR; Follath F; Solèr M; Vallotton M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S119-23. PubMed ID: 2446058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ketanserin on blood pressure and biochemical parameters in patients with essential hypertension.
    Wing LM; Chalmers JP; West MJ; Bune AJ; Ayres B; Graham JR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S164-7. PubMed ID: 2412043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of ketanserin on blood pressure and biochemical parameters in treated patients with essential hypertension.
    Wing LM; Chalmers JP; West MJ; Bune AJ; Ayres B; Graham JR
    Clin Exp Hypertens A; 1984; 6(6):1107-17. PubMed ID: 6146414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketanserin combined with a beta-blocker or diuretic in essential hypertension. A multicentre study.
    Bartoloni C; Dupont P; Feltkamp H; Johnston CI; Steinbach K; Zilcher H; Kaindl F
    Eur J Clin Pharmacol; 1988; 35(6):573-7. PubMed ID: 2906874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin antagonism reduces the adverse symptoms of beta blockade.
    Korlipara K; Gould SE; Taylor NA; Chandler A
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():127-31. PubMed ID: 1981022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic blockade compared with beta-adrenergic blockade in systemic hypertension: a double-blind comparison of ketanserin with propranolol.
    Okin S; Huberfeld SI; Frishman WH; Soberman J; Laifer L; Greenberg S; Lapsker J; Charlap S; Strom JA
    J Clin Pharmacol; 1988 Nov; 28(11):1008-16. PubMed ID: 2907519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketanserin in the treatment of essential hypertension. A double-blind study against metoprolol and a further long-term open treatment.
    Milei J; Lemus J; Bernardiner E
    Acta Cardiol; 1986; 41(6):427-41. PubMed ID: 3544622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood pressure lowering action and tolerance of ketanserin in mono- or combination therapy].
    Beretta-Piccoli C; Amstein R; Bühler FR; Bertel O; Brunner HR; Follath F; Reutter F; Vallotton MB
    Schweiz Med Wochenschr; 1989 Mar; 119(12):399-406. PubMed ID: 2711155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive efficacy and well-being during monotherapy and combination therapy with ketanserin.
    Amstein R; Bühler FR; Beretta-Piccoli C; Bertel O; Brunner HR; Follath F; Heer K; Reutter F; Vallotton MB
    J Hypertens; 1989 Aug; 7(8):619-24. PubMed ID: 2809191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive therapy with ketanserin: metabolic and hemodynamic effects.
    Levinson PD; Zimlichman R; Goldstein DS; Keiser HR
    J Cardiovasc Pharmacol; 1988 Oct; 12(4):384-9. PubMed ID: 2465437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Felodipine in hypertensive patients. A dose finding study in patients refractory to beta-blocker monotherapy.
    Sluiter HE
    Drugs; 1987; 34 Suppl 3():97-106. PubMed ID: 2894980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A cross-over study of ketanserin compared to placebo, beta-adrenergic blockader, diuretic and alpha 1-adrenergic blockader. Cooperative research in the USSR (the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension). Working Group (4)].
    Metelitsa VI; Filatova NP
    Ter Arkh; 1991; 63(9):91-6. PubMed ID: 1684678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
    Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketanserin in combination with beta-adrenergic receptor blocking agents in the treatment of essential hypertension.
    Hedner T; Persson B
    Br J Clin Pharmacol; 1984 Nov; 18(5):765-71. PubMed ID: 6150724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind comparative study of ketanserin with atenolol in essential hypertension.
    Antonicelli R; Andreoni A; Saccomanno G; Gambini C; Paciaroni E
    Drugs Exp Clin Res; 1989; 15(11-12):577-81. PubMed ID: 2700320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term experience of felodipine in combination with beta-blockade and diuretics in refractory hypertension.
    Collste P; Danielsson M; Elmfeldt D; Feleke E; Gelin A; Hedner T; Rydén L
    Drugs; 1985; 29 Suppl 2():124-30. PubMed ID: 2859184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with terazosin administered in combination with other antihypertensive agents.
    Chrysant SG
    Am J Med; 1986 May; 80(5B):55-61. PubMed ID: 2872808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive efficacy of the calcium-antagonist felodipine in patients with persisting hypertension on beta-adrenoceptor blocker therapy. The Canadian Felodipine Study Group.
    Br J Clin Pharmacol; 1988 Nov; 26(5):535-45. PubMed ID: 2905154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.